Molecular mechanisms in the pathogenesis of AIDS-associated Kaposi's sarcoma
- PMID: 1805571
- DOI: 10.1007/978-1-4684-6000-1_4
Molecular mechanisms in the pathogenesis of AIDS-associated Kaposi's sarcoma
Abstract
Kaposi's Sarcoma (KS) is a tumor of mesenchymal origin of unclear etiology and pathogenesis. The epidemic form of KS (AIDS-associated) occurs in up to 30% of HIV-1 infected individuals with lesions characterized by mixed cellularity, spindle cells proliferation and neoangiogenesis. The establishment of in vitro and in vivo model systems (AIDS-KS cell cultures and nude mouse) have allowed studies toward the understanding of the pathogenesis of KS. The data presented here support the hypothesis that KS is a cytokine mediated disease and that interactions between mesenchymal cell types and HIV-1 gene products might lead to a composite lesion such as KS. In fact, in vitro and in vivo studies indicate that the HIV-1 Tat protein acts as a growth factor for cells derived from AIDS-KS lesions, thus establishing an experimental link between HIV-1 infection and the development of KS in humans. Human immunodeficiency virus (HIV-1) is implicated in various clinical manifestations associated with AIDS, including KS. KS represents the most frequent tumor arising in infected individuals, particularly homosexual and bisexual men. This form of KS (epidemic or AIDS-KS) is aggressive and often results in dissemination and invasion of lymph nodes and viscera. Histologically, KS is characterized by the proliferation of spindle-shaped cells ("KS cells"), considered to be the tumor element of the lesions, associated with endothelial cells, fibroblasts, inflammatory cells and new blood vessel formation (early stage lesions). In a later stage, the spindle cells tend to coalesce in larger tumor masses, although the slit-like spaces, which are characteristic of the lesion, usually remain evident. The histogenesis of the KS spindle cells, however, is still controversial and both types of mesenchymal cells, endothelial and smooth muscle cells, have been proposed as potential cell progenitors. Although KS is clearly associated with HIV-1 infection, little is known about the molecular events underlying its pathogenesis. Recently, however, two experimental advances (the establishment of long-term cell cultures derived from KS lesions of AIDS patients and the development of animal models) have made the study of the pathogenesis of AIDS-KS possible. Here we discuss results obtained from these new systems suggesting that the induction of the AIDS-KS lesions involves a pathway of events mediated by specific cytokines and that the HIV-1 tat gene product may play a crucial role in the development and/or progression of KS in HIV-1 infected individuals.
Similar articles
-
Pathogenesis of AIDS-associated Kaposi's sarcoma.Hematol Oncol Clin North Am. 1991 Apr;5(2):281-95. Hematol Oncol Clin North Am. 1991. PMID: 2022594 Review.
-
Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.J Clin Invest. 1995 Apr;95(4):1723-34. doi: 10.1172/JCI117849. J Clin Invest. 1995. PMID: 7535796 Free PMC article.
-
Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.J Immunol. 1999 Aug 15;163(4):1929-35. J Immunol. 1999. PMID: 10438928
-
Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.Biochem Biophys Res Commun. 2000 Jun 24;273(1):267-71. doi: 10.1006/bbrc.2000.2941. Biochem Biophys Res Commun. 2000. PMID: 10873597
-
The role of human immunodeficiency virus-I in the pathogenesis of acquired immunodeficiency syndrome-related Kaposi's sarcoma: the importance of an inflammatory and angiogenic milieu.Semin Oncol. 2000 Aug;27(4):420-3. Semin Oncol. 2000. PMID: 10950368 Review.
Cited by
-
Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers.Antiviral Res. 2007 Jan;73(1):12-23. doi: 10.1016/j.antiviral.2006.05.017. Epub 2006 Jun 14. Antiviral Res. 2007. PMID: 16842866 Free PMC article.
-
Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection.Clin Exp Immunol. 1994 Apr;96(1):59-63. doi: 10.1111/j.1365-2249.1994.tb06230.x. Clin Exp Immunol. 1994. PMID: 8149667 Free PMC article.
-
γδ T-cell responses during HIV infection and antiretroviral therapy.Clin Transl Immunology. 2019 Jul 17;8(7):e01069. doi: 10.1002/cti2.1069. eCollection 2019. Clin Transl Immunology. 2019. PMID: 31321033 Free PMC article. Review.
-
Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus.Am J Pathol. 2005 Jan;166(1):173-83. doi: 10.1016/S0002-9440(10)62242-0. Am J Pathol. 2005. PMID: 15632010 Free PMC article.
-
Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis.Am J Pathol. 1999 Nov;155(5):1731-9. doi: 10.1016/S0002-9440(10)65488-0. Am J Pathol. 1999. PMID: 10550329 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical